ABSTRACT: Post-transplant lymphoproliferative disorder (PTLD) is often associated with Epstein-Barr virus (EBV). However, in this report, we describe a heart transplant recipient with pathologically proven EBV-positive PTLD with undetectable virus by polymerase chain reaction. The patient had remission after anti-CD20 antibody treatment early after transplantation.
The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation 08/2008; 27(8):928-31. · 3.54 Impact Factor